{
    "2019-07-22": [
        [
            {
                "time": "2018-01-03",
                "original_text": "The 10 Biggest Blue Chip Stocks",
                "features": {
                    "keywords": [
                        "Biggest",
                        "Blue Chip",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Microsoft",
                        "JPMorgan",
                        "Merck",
                        "Johnson & Johnson",
                        "IBM"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Relative Strength Alert For Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Relative",
                        "Strength",
                        "Alert",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "J&J in hot water after safety lawsuits over baby powder",
                "features": {
                    "keywords": [
                        "J&J",
                        "hot water",
                        "safety",
                        "lawsuits",
                        "baby powder"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Johnson & Johnson faces more than 14k lawsuits over talc products",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "lawsuits",
                        "talc",
                        "products"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal",
                "features": {
                    "keywords": [
                        "Equifax",
                        "CBS",
                        "AT&T",
                        "Vail",
                        "Peak",
                        "ski deal"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "media",
                        "recreation"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "UPDATE 3-Congo minister's resignation over Ebola snub could unblock new vaccine",
                "features": {
                    "keywords": [
                        "Congo",
                        "minister",
                        "resignation",
                        "Ebola",
                        "vaccine"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Is a Beat in Store for AbbVie (ABBV) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Beat",
                        "Store",
                        "AbbVie",
                        "Earnings",
                        "Season"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Stocks Slip This Week on Earnings, Fed Uncertainties",
                "features": {
                    "keywords": [
                        "Stocks",
                        "Slip",
                        "Earnings",
                        "Fed",
                        "Uncertainties"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "Is Johnson & Johnson a Buy?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}